The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
The University of Cape Town’s (UCT) vice-chancellor, Professor Mamokgethi Phakeng, will be one of five speakers at the re-launch of the Life Science Across the Globe (LSAG) as a monthly seminar series.
If the current rate of COVID-19 vaccination continues, global herd immunity will be reached in 2025. Not only would this trajectory create conditions that fuel new variants, but it will leave out the world’s poorest countries.
A One Health approach to vaccine development has many strengths, including for health and food security on the continent. But this country needs to boost its capacity now, write Professor Ed Rybicki and Professor Anna-Lise Williamson from the University of Cape Town (UCT) and Baptiste Dungu, the chief executive of Onderstepoort Biological Products.
In a paper recently published in the Journal of Bacteriology, researchers at the Institute of Infectious Disease and Molecular Medicine (IDM) at the University of Cape Town’s Faculty of Health Sciences show that Mycobacterium smegmatis, a soil-dwelling model for Mycobacterium tuberculosis (M. tb), produces its own cobalamin, a form of vitamin B12 which is required in a number of central metabolic pathways. The paper also describes the conditions under which this bacterium efficiently takes up the vitamer from growth media.